News Release

Archive

Top Message

Bringing Meaningful Value to the Future of Healthcare

We want to help create a future where people can live healthier, more fulfilling lives in their own way. As society continues to change, the challenges we face are becoming more complex. An aging population, increasingly diverse medical needs, and changes in the global environment are all reshaping healthcare. At a time like this, we believe it is important to look closely at human life through the power of science, and to contribute to the future of healthcare through our work in pharmaceuticals.

Medical science and technology continue to advance, opening new possibilities for healthcare. Their value is fully realized when these advances are translated into solutions that reach patients and healthcare professionals and help address real challenges in medical care.

At ZENOGEN PHARMA, we place great importance on creating new value through science and making it useful for society. We are working to develop technologies that may lead to next-generation medicines for cancers and other diseases that remain difficult to treat. Together with partners who share our vision, we aim to nurture these technologies into new therapeutic options. We also provide products and services that help researchers and companies advance drug discovery and life science research.

Through these efforts, we aim to be a company that turns the potential of science into meaningful solutions for patients and society. With belief in science and a spirit of challenge, we will continue to move forward — helping to ease the burden on patients and contributing to healthier, more fulfilling lives.

Business information

Three Business Areas Connected to the Future of Healthcare

ZENOGEN PHARMA operates in three business areas: Drug Discovery, which aims to create next-generation medicines; Technology Platform, which supports drug discovery; and Products and Services, which support life science research and the front lines of drug discovery.

By leveraging the strengths of each area, we aim to turn technologies and insights born from research into value that benefits society.

  • Drug Discovery
  • Technology Platform
  • Products and Services
  • Creating value that can lead to next-generation medicines

    We are working to create next-generation medicines that may provide new therapeutic options for cancers and other diseases that remain difficult to treat. Using highly specific antibodies as a foundation, we are advancing drug discovery research with a focus on antibody-drug conjugates, or ADCs.

    As our programs progress, we also seek to enhance their value through partnerships such as licensing and co-development, with the aim of nurturing them into medicines that can ultimately reach patients.

  • Competitive strengths that support drug discovery

    We are developing antibody technologies and bio-conjugation technologies as a technology platform to support the creation of next-generation medicines.
    These technologies are applied to our own drug discovery research and may also serve as a source of competitive strength in collaborative research and co-development with external partners.

    Through continuous technology development, we aim to connect research outcomes to drug discovery and, ultimately, to future medical value.

  • Providing Value that Supports Research and Drug Discovery

    Centered on CELLBANKER, our cell freezing media product line, we provide products and services for life science research, drug discovery, regenerative medicine, and other healthcare-related fields.
    CELLBANKER is used not only in research and drug discovery, but also in cell banking for biopharmaceutical development. As cell and gene therapy products advance from development to commercialization, CELLBANKER may also become an important part of the manufacturing process, contributing to the stable production of advanced medical products.

    With a focus on stable quality and reliable supply, we provide these products and services to universities, companies, research institutions, and a wide range of healthcare-related partners. In this way, we aim to contribute to the creation of value connected to the future of healthcare.

Corporate Profile

Corporate Name: ZENOGEN PHARMA CO., LTD.
Office: 1-1 Tairanoue, Sasagawa, Asaka-machi, Koriyama, Fukushima, 963-0102 Japan
Representative: Masato Fukui
Date of Establishment: April 1985
Capital: 100 million yen
Core Business: Research, development, manufacturing, and sales of products and services relating to life science field.
Group Company: ZENOAQ HOLDINGS CO., LTD.
NIPPON ZENYAKU KOGYO CO., LTD. (ZENOAQ)
zenogen_pharma-post@zenoaq.jp